君實生物(688180.SH/1877.HK)榮獲2020年度抗疫傑出貢獻獎
格隆匯11月17日丨由格隆匯主辦的“格隆匯·全球投資嘉年華·2020”正在四川成都世紀城國際會議中心順利進行。在昨晚舉行的“大中華區最佳上市公司頒獎典禮”上,君實生物(688180.SH/1877.HK)榮獲2020年度抗疫傑出貢獻獎。2020年初新冠肺炎疫情爆發後,面對這次影響面極廣的公共事件,君實生物(688180.SH/1877.HK)勇於承擔社會責任,響應國家號召,積極籌備醫療物資支援一線抗疫人員,有序安排復工事宜,與全國人民同舟共濟,共克時艱。眾志成城的力量,是戰勝疫情的重要因素,君實生物以實際行動踐行企業的社會責任與義務,與社會同擔當、共進退。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.